GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
51 hedge funds and large institutions have $54.9M invested in Aevi Genomic Medicine Inc in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
51
Holding in Top 10
1
Calls
$322K
Puts
$9K
Top Buyers
| 1 | +$3.37M | |
| 2 | +$2.09M | |
| 3 | +$1.29M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$993K |
| 5 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
+$929K |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$266K | |
| 3 | -$95K | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$87K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$40.4K |